Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pentobarbitone formation during thiopentone infusion.

H N Chan, D J Morgan, D P Crankshaw

    Anaesthesia
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The pharmacokinetics of ganciclovir during prolonged intermittent kidney replacement therapy in a cardiac transplant recipient.

    Journal of chemotherapy (Florence, Italy)·2024
    Same author

    A Non-Controlled Study of a Multi-Factorial Exercise and Nutritional Intervention to Improve Functional Performance and Prevent Frailty Progression in Community-Dwelling Pre-Frail Older Adults.

    JAR life·2023
    Same author

    Experimental and Theoretical Study of the Electronic Structures of Lanthanide Indium Perovskites LnInO<sub>3</sub>.

    The journal of physical chemistry. C, Nanomaterials and interfaces·2021
    Same author

    Risk factors for transmission of carbapenem-resistant Enterobacterales to healthcare personnel gloves and gowns in the USA.

    The Journal of hospital infection·2020
    Same author

    The deposition of metal nanoparticles on carbon surfaces: the role of specific functional groups.

    Faraday discussions·2018
    Same author

    Adverse outcomes after planned surgery with anticipated intensive care admission in out-of-office-hours time periods: a multicentre cohort study.

    British journal of anaesthesia·2018
    Same journal

    Management of major thoracic trauma: a narrative review.

    Anaesthesia·2026
    Same journal

    Pulmonary artery catheters or central venous catheters for cardiac surgery: the PUMA Pilot randomised clinical trial.

    Anaesthesia·2026
    Same journal

    Opioid-free vs. opioid-inclusive anaesthesia with or without regional anaesthesia for postoperative pain.

    Anaesthesia·2026
    Same journal

    Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention: a reply.

    Anaesthesia·2026
    Same journal

    Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention.

    Anaesthesia·2026
    Same journal

    Pain control or brain protection with esketamine: a reply.

    Anaesthesia·2026
    See all related articles

    Pentobarbitone, an active metabolite of thiopentone anesthesia, reached low plasma concentrations in surgical patients. Its formation is unlikely to be clinically relevant for short infusions but may increase with longer durations.

    Area of Science:

    • Pharmacology
    • Anesthesiology
    • Clinical Chemistry

    Background:

    • Thiopentone is a common anesthetic agent.
    • Pentobarbitone is a known active metabolite of thiopentone.
    • Understanding metabolite pharmacokinetics is crucial for patient safety.

    Purpose of the Study:

    • To determine plasma concentrations and elimination half-life of pentobarbitone.
    • To assess the clinical relevance of pentobarbitone formation during thiopentone infusion.
    • To investigate the impact of infusion duration on pentobarbitone levels.

    Main Methods:

    • Continuous, exponentially decreasing infusion of thiopentone in 14 surgical patients.
    • Measurement of plasma pentobarbitone and thiopentone concentrations.

    Related Experiment Videos

  • Determination of pentobarbitone elimination half-life over 70 hours in nine patients.

    • Main Results:

    • Peak plasma pentobarbitone concentration was 1.49 µg/ml (SD 0.61) at the end of infusion.
    • Pentobarbitone represented 15.5% (SD 6.04) of plasma thiopentone concentration.
    • Pentobarbitone elimination half-life was 34.3 hours (SD 8.2), consistent with previous studies.

    Conclusions:

    • Pentobarbitone formation during 2-3 hour thiopentone infusions is unlikely to be clinically significant.
    • Higher pentobarbitone concentrations may occur with prolonged thiopentone infusions.
    • Further research is needed to evaluate the clinical impact of pentobarbitone accumulation in longer infusions.